Literature DB >> 22101771

Anesthetic management of a pediatric patient with neuroleptic malignant syndrome.

Tarun Bhalla1, Douglas Maxey, Amod Sawardekar, Joseph D Tobias.   

Abstract

Neuroleptic malignant syndrome (NMS) is a rare disorder which is clinically similar to malignant hyperthermia (MH). It is characterized by hyperthermia, autonomic instability, muscle rigidity, coma, rhabdomyolysis, and acidosis. Without immediate and appropriate therapy, mortality may result. NMS is associated with administration of antipsychotic medications, anti-emetic medications, and changes in the dosage of anti-parkinsonian drugs. As several similarities exist between NMS and MH, differentiating between them can be a challenge for the clinician. We report anesthetic care during magnetic resonance imaging of the brain of a 14-year-old female with bipolar and schizoaffective disorders and the recent onset of NMS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101771     DOI: 10.1007/s00540-011-1269-2

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  18 in total

1.  Droperidol-induced neuroleptic malignant syndrome.

Authors:  J Edgar
Journal:  Hosp Med       Date:  1999-06

Review 2.  Neuroleptic malignant syndrome.

Authors:  P Adnet; P Lestavel; R Krivosic-Horber
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

Review 3.  Neuroleptic malignant syndrome: mechanisms, interactions, and causality.

Authors:  P Ken Gillman
Journal:  Mov Disord       Date:  2010-09-15       Impact factor: 10.338

4.  Neuroleptic malignant syndrome induced by droperidol.

Authors:  P C So
Journal:  Hong Kong Med J       Date:  2001-03       Impact factor: 2.227

Review 5.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

6.  The association between the neuroleptic malignant syndrome and malignant hyperthermia.

Authors:  P J Adnet; R M Krivosic-Horber; M M Adamantidis; G Haudecoeur; C A Adnet-Bonte; F Saulnier; B A Dupuis
Journal:  Acta Anaesthesiol Scand       Date:  1989-11       Impact factor: 2.105

7.  A case of neuroleptic malignant syndrome successfully treated with amantadine.

Authors:  M M McCarron; M L Boettger; J J Peck
Journal:  J Clin Psychiatry       Date:  1982-09       Impact factor: 4.384

8.  A successful electroconvulsive treatment of neuroleptic malignant syndrome.

Authors:  H Hermesh; D Aizenberg; A Weizman
Journal:  Acta Psychiatr Scand       Date:  1987-03       Impact factor: 6.392

Review 9.  Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review.

Authors:  Rachel Neuhut; Jean-Pierre Lindenmayer; Raul Silva
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-08       Impact factor: 2.576

10.  Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.

Authors:  R Krivosic-Horber; P Adnet; E Guevart; D Theunynck; P Lestavel
Journal:  Br J Anaesth       Date:  1987-12       Impact factor: 9.166

View more
  1 in total

1.  Serotonin syndrome with escitolapram and concomitant use of cocaine: a case report.

Authors:  Hamood Ur-Rehman Malik; Krishan Kumar
Journal:  Clin Med Insights Case Rep       Date:  2012-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.